Coulston James bought PROK
March 1, 2026 · Form 4 insider transaction
Coulston James bought 600,000 shares of ProKidney Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
600,000
Price
$0.00
Total value
N/A
InsiderCoulston James
RoleOfficer
CompanyProKidney Corp. (PROK)
SecurityEmployee stock option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after600,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2026.